This is a Validated Antibody Database (VAD) review about human PDE3A, based on 3 published articles (read how Labome selects the articles), using PDE3A antibody in all methods. It is aimed to help Labome visitors find the most suited PDE3A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PDE3A synonym: CGI-PDE; CGI-PDE A; CGI-PDE-A; HTNB; cGMP-inhibited 3',5'-cyclic phosphodiesterase A; cAMP phosphodiesterase, myocardial cGMP-inhibited; cyclic GMP-inhibited phosphodiesterase A; phosphodiesterase 3A, cGMP-inhibited

Abcam
rabbit monoclonal (EPR11601)
  • western blot; human; loading ...; fig 2b
Abcam PDE3A antibody (Abcam, ab169534) was used in western blot on human samples (fig 2b). Eur Rev Med Pharmacol Sci (2017) ncbi
LifeSpan Biosciences
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 5a
LifeSpan Biosciences PDE3A antibody (LifeSpan, LS-A732) was used in immunohistochemistry - paraffin section on human samples (fig 5a). BMC Cancer (2016) ncbi
Bethyl
rabbit polyclonal
  • western blot; human
In order to discuss the contribution of missense mutations in PDE3A to hypertension, Bethyl PDE3A antibody (Bethyl Laboratories, A302-740A) was used in western blot on human samples . Nat Genet (2015) ncbi
Articles Reviewed
  1. Tian F, Zhong C, Wang X, Meng Y. PDE3A is hypermethylated in cisplatin resistant non-small cell lung cancer cells and is a modulator of chemotherapy response. Eur Rev Med Pharmacol Sci. 2017;21:2635-2641 pubmed
  2. Mahmood B, Damm M, Jensen T, Backe M, Dahllöf M, Poulsen S, et al. Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia. BMC Cancer. 2016;16:938 pubmed
  3. Maass P, Aydin A, Luft F, Schächterle C, Weise A, Stricker S, et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat Genet. 2015;47:647-53 pubmed publisher